studyType

141 triples

GPTKB property

studyDesign

Subject	Object
gptkb:LEADERS_II	randomized
gptkb:CLARITY-AD	randomized
gptkb:NCT04513366	Interventional
gptkb:PROTECT_AF	gptkb:clinical_trial
gptkb:A_Phase_3,_Randomized,_Double-blind,_Placebo-controlled_Study_to_Evaluate_the_Efficacy_and_Safety_of_Tezepelumab_in_Adults_and_Adolescents_With_Severe,_Uncontrolled_Asthma_(NAVIGATOR)	placebo-controlled
gptkb:All_of_Us_Research_Program	gptkb:longitudinal_study
gptkb:Women's_Health_Initiative	observational study
gptkb:Rivaroxaban_Once_Daily_Oral_Direct_Factor_Xa_Inhibition_Compared_with_Vitamin_K_Antagonism_for_Prevention_of_Stroke_and_Embolism_Trial_in_Atrial_Fibrillation	gptkb:clinical_trial
gptkb:CALM_trial	gptkb:clinical_trial
gptkb:SDY-040	immunology study
gptkb:IRS_(Intergroup_Rhabdomyosarcoma_Study)	multi-institutional
gptkb:RE-LY_trial	blinded endpoint evaluation
gptkb:PREPARE	gptkb:clinical_trial
gptkb:ROCKET_trial	randomized
gptkb:CLARITY-AD	double-blind
gptkb:SURPASS-5	parallel assignment
gptkb:CFAS_II	longitudinal
gptkb:Sweet_Heart_Failure_with_Preserved_Ejection_Fraction:_Randomized_Trial	gptkb:clinical_trial
gptkb:NCT04505722	Interventional
gptkb:NCT01449370	Randomized